We are live on
!
Find out more
PA
Pinnacle Associates Portfolio holdings
AUM
$7.78B
1-Year Est. Return
45.07%
This Fund
S&P 500
This Quarter
Est. Return
+1.57%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$4.25B
AUM Growth
-$25.4M
(-0.6%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
0.29%
Top 10 Holdings %
Top 10 Hldgs %
16.34%
Holding
741
New
37
Increased
257
Reduced
342
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$29.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$12.5M |
| 3 |
AERI
Aerie Pharmaceuticals
AERI
|
+$10.4M |
| 4 |
CME Group
CME
|
+$10.1M |
| 5 |
TVRD
Tvardi Therapeutics
TVRD
|
+$8.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
+$38.8M |
| 2 |
FNSR
Finisar Corp
FNSR
|
+$16.2M |
| 3 |
Lam Research
LRCX
|
+$11.3M |
| 4 |
Merck
MRK
|
+$9.45M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$7.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.59% |
| 2 | Communication Services | 12.14% |
| 3 | Industrials | 11.8% |
| 4 | Healthcare | 11.37% |
| 5 | Financials | 8.53% |
Similar funds
EHC
IMCOOI
PGFC
WRCM
WF
SIAU
BFM
SF
Pinnacle Associates's Q3 2019 Portfolio in Review
As of Q3 2019, Pinnacle Associates held 741 positions worth $4.25B, down 0.6% from $4.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Pinnacle Associates's Q3 2019 filing shows 37 new, 257 increased, 342 reduced and 37 closed positions. Its largest new stake was Aerie Pharmaceuticals: 454,750 shares worth $8.74M. The largest sale was Array Biopharma Inc, an estimated $38.8M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Communication Services and Industrials.
- Pinnacle Associates's largest Q3 2019 buy was Aerie Pharmaceuticals: 454,750 shares worth $8.74M.
- Pinnacle Associates added most to Apple in Q3 2019, an estimated $29.8M increase.
- Pinnacle Associates's biggest Q3 2019 reduction was Lam Research, cutting an estimated $11.3M.
- Pinnacle Associates fully exited Array Biopharma Inc in Q3 2019, selling an estimated $38.8M.
- Pinnacle Associates's ten largest holdings make up 16% of its $4.25B portfolio in Q3 2019.
- Pinnacle Associates opened 37 new positions and closed 37 in Q3 2019.
- Pinnacle Associates's portfolio value fell 0.6% quarter-over-quarter to $4.25B.
Based on Pinnacle Associates's 13F filing for Q3 2019, filed 8 Nov 2019.